Avalon Investment & Advisory’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $78.4M | Sell |
736,753
-19,639
| -3% | -$2.12M | 2.15% | 7 |
|
|
2022
Q4 | $83.9M | Sell |
756,392
-3,341
| -0.4% | -$342K | 2.39% | 5 |
|
|
2022
Q3 | $65.4M | Sell |
759,733
-17,622
| -2% | -$1.57M | 2.03% | 8 |
|
|
2022
Q2 | $70.9M | Buy |
777,355
+2,490
| +0.3% | +$221K | 2% | 4 |
|
|
2022
Q1 | $63.6M | Buy |
774,865
+17,034
| +2% | +$1.34M | 1.54% | 12 |
|
|
2021
Q4 | $58.1M | Sell |
757,831
-65,855
| -8% | -$5.25M | 1.43% | 21 |
|
|
2021
Q3 | $61.9M | Sell |
823,686
-5,675
| -0.7% | -$432K | 1.43% | 17 |
|
|
2021
Q2 | $64.5M | Buy |
829,361
+73,504
| +10% | +$5.47M | 1.43% | 16 |
|
|
2021
Q1 | $55.6M | Sell |
755,857
-321,731
| -30% | -$23.7M | 1.27% | 17 |
|
|
2020
Q4 | $84.1M | Sell |
1,077,588
-23,379
| -2% | -$1.79M | 1.71% | 12 |
|
|
2020
Q3 | $87.1M | Sell |
1,100,967
-64,391
| -6% | -$5.04M | 1.94% | 10 |
|
|
2020
Q2 | $86M | Sell |
1,165,358
-93,089
| -7% | -$7.01M | 1.98% | 9 |
|
|
2020
Q1 | $92.4M | Sell |
1,258,447
-115,366
| -8% | -$9.07M | 2.36% | 7 |
|
|
2019
Q4 | $119M | Buy |
1,373,813
+22,235
| +2% | +$1.83M | 2.44% | 5 |
|
|
2019
Q3 | $109M | Buy |
1,351,578
+10,998
| +0.8% | +$881K | 2.4% | 5 |
|
|
2019
Q2 | $107M | Buy |
1,340,580
+128,748
| +11% | +$9.86M | 2.38% | 5 |
|
|
2019
Q1 | $96.2M | Buy |
1,211,832
+26,367
| +2% | +$1.97M | 2.19% | 8 |
|
|
2018
Q4 | $86.4M | Buy |
1,185,465
+216,424
| +22% | +$15.3M | 2.23% | 6 |
|
|
2018
Q3 | $65.6M | Buy |
969,041
+18,219
| +2% | +$1.16M | 1.84% | 2 |
|
|
2018
Q2 | $55.1M | Buy |
950,822
+87,589
| +10% | +$4.94M | 1.63% | 7 |
|
|
2018
Q1 | $44.9M | Buy |
863,233
+157,093
| +22% | +$8.48M | 1.39% | 10 |
|
|
2017
Q4 | $37.9M | Sell |
706,140
-63,980
| -8% | -$3.55M | 1.19% | 17 |
|
|
2017
Q3 | $47.1M | Buy |
770,120
+5,181
| +0.7% | +$314K | 1.5% | 10 |
|
|
2017
Q2 | $46.8M | Buy |
764,939
+23,595
| +3% | +$1.44M | 1.55% | 7 |
|
|
2017
Q1 | $44.9M | Buy |
741,344
+6,230
| +0.8% | +$378K | 1.54% | 8 |
|
|
2016
Q4 | $41.3M | Buy |
735,114
+74,299
| +11% | +$4.35M | 1.49% | 12 |
|
|
2016
Q3 | $39.4M | Sell |
660,815
-74,321
| -10% | -$4.35M | 1.48% | 12 |
|
|
2016
Q2 | $40.4M | Buy |
735,136
+187,487
| +34% | +$9.98M | 1.56% | 15 |
|
|
2016
Q1 | $27.6M | Buy |
547,649
+6,030
| +1% | +$295K | 1.2% | 26 |
|
|
2015
Q4 | $27.3M | Sell |
541,619
-32,656
| -6% | -$1.65M | 1.18% | 23 |
|
|
2015
Q3 | $27.1M | Buy |
574,275
+20,831
| +4% | +$1.11M | 1.19% | 22 |
|
|
2015
Q2 | $30.1M | Buy |
553,444
+823
| +0.1% | +$46.2K | 1.29% | 18 |
|
|
2015
Q1 | $30.3M | Buy |
552,621
+14,718
| +3% | +$833K | 1.32% | 18 |
|
|
2014
Q4 | $29.1M | Sell |
537,903
-47,530
| -8% | -$2.65M | 1.33% | 18 |
|
|
2014
Q3 | $33.1M | Buy |
585,433
+2,938
| +0.5% | +$165K | 1.67% | 11 |
|
|
2014
Q2 | $32.2M | Buy |
582,495
+6,816
| +1% | +$372K | 1.63% | 15 |
|
|
2014
Q1 | $31.2M | Buy |
575,679
+138,846
| +32% | +$7.19M | 1.72% | 13 |
|
|
2013
Q4 | $20.9M | Buy |
436,833
+1,826
| +0.4% | +$83.5K | 1.17% | 21 |
|
|
2013
Q3 | $19.8M | Sell |
435,007
-17,719
| -4% | -$809K | 1.28% | 19 |
|
|
2013
Q2 | $20.1M | Buy |
+452,726
| New | +$20.2M | 1.2% | 22 |
|
Other funds holding MRK
Avalon Investment & Advisory's MRK Position: Q1 2023 in Review
Avalon Investment & Advisory reduced its Merck (MRK) stake by 2.6% in Q1 2023, selling an estimated $2.12M and leaving 736,753 shares worth $78.4M. The position accounts for 2.15% of the portfolio, ranked #7.
Avalon Investment & Advisory first reported a position in MRK in Q2 2013 and has held it in 40 quarters since. The position peaked at $119M in Q4 2019. 3,179 funds tracked by Wall St. Rank hold MRK as of Q1 2023.
- Avalon Investment & Advisory held 736,753 shares of Merck worth $78.4M as of Q1 2023.
- Avalon Investment & Advisory sold 19,639 Merck shares in Q1 2023, an estimated $2.12M.
- Merck made up 2.15% of Avalon Investment & Advisory's portfolio in Q1 2023, its #7 holding.
- Avalon Investment & Advisory first reported a position in Merck in Q2 2013 and has held it in 40 quarters since.
- Avalon Investment & Advisory's Merck position peaked at $119M in Q4 2019.
- 3,179 funds tracked by Wall St. Rank held Merck as of Q1 2023.
Based on Avalon Investment & Advisory's 13F filing for Q1 2023, filed 15 May 2023.